Gene study aims to unlock secrets of progressive lung disease

NCT ID NCT07580053

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 250 Italian adults with genetic forms of pulmonary fibrosis to see how their lung function changes over time. Researchers will track breathing tests and compare patients who receive immune-modulating drugs with those who do not. The goal is to understand how inherited factors influence the speed of lung scarring.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors predict how lung fibrosis will progress based on a patient's genes, leading to more personalized care.

What could go wrong

This is an observational study, not a treatment trial. It will not directly improve health, and results may not apply to all patients with lung fibrosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROGRESSIVE PULMONARY FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

idiopathic pulmonary fibrosis inherited interstitial lung disease interstitial lung disease pulmonary fibrosis telomere syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Francesco Amati

    Rozzano, Italy, 20089, Italy